Consistent with our previous studies, which demonstrated that the mRNA expression of RIPK3 and MLKL is lower in the normal bile duct compared to CCA tissues [8], we further validated these findings in tissue samples from CCA patients using immunohistochemistry (IHC). This evidence concerns the gene MLKL and cholangiocarcinoma.